2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Endometrial Biopsy
Endometrial biopsy plays a pivotal role in cancer research, particularly in the study of endometrial cancer. This procedure involves the extraction of a small tissue sample from the lining of the uterus, known as the endometrium, for microscopic examination. Researchers utilize these biopsies to investigate various aspects of endometrial cancer, including its etiology, progression, and response to treatment. By analyzing the cellular composition and genetic characteristics of these samples, scientists can identify biomarkers, predict patient outcomes, and develop targeted therapies. Furthermore, endometrial biopsies contribute to the advancement of personalized medicine by enabling tailored treatment strategies based on individual tumor profiles. Thus, endometrial biopsy serves as a valuable tool in advancing our understanding of endometrial cancer and improving patient care through precision oncology approaches.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China